SEC Filing Summary: Landec Corporation (Form 8-K)
Business Context and Reporting Period
This Form 8-K was filed by Landec Corporation on March 30, 2012. The report discloses a specific corporate governance event regarding the departure of a senior executive. Note: The request metadata references "LIFECORE BIOMEDICAL, INC.", but the filing text explicitly identifies the registrant as "LANDEC CORPORATION".
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report is limited to personnel changes and does not contain financial statements or performance data.
Material Changes
The material change reported is the retirement of David D. Taft as Chief Operating Officer, effective March 30, 2012.
Guidance, Outlook, and Risks
The filing contains no management commentary, financial guidance, outlook, or discussion of risks and contingencies beyond the executive departure.
Key Facts for Investor Verification
- David D. Taft retired as Chief Operating Officer on March 30, 2012.
- The filing is signed by Gregory S. Skinner, Vice President of Finance and Chief Financial Officer.
- Verify if a successor to the Chief Operating Officer role has been appointed or if the role is being eliminated.
- Confirm the distinction between the registrant (Landec Corporation) and the company name in the request metadata (Lifecore Biomedical, Inc.).